Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 0.06% of BIO-B shares are held by financial institutions. CSS LLC/IL is the top corporate investor, holding 1.09K shares valued at $309.01K. A 0% stake in Bio-Rad Laboratories, Inc. is owned by the company. UBS GROUP AG owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the BIO-B insiders holding of 98.05% of the stake in company, GOETZ JOHN, EVP, Chief Operating Officer, holds the largest shares of 61.17K. MAGNI GIOVANNI, EVP, Chief Strategy Officer, is the second largest BIO-B insider with ownership of 20.74K shares. HERTIA JOHN, Executive Vice President, stands third with possession of 18.73K shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| GOETZ JOHN | EVP, Chief Operating Officer | 61.17K |
| MAGNI GIOVANNI | EVP, Chief Strategy Officer | 20.74K |
| HERTIA JOHN | Executive Vice President | 18.73K |
| CROWLEY MICHAEL | EVP, GBL Commercial Operations | 6.94K |
| TSINGOS CHRISTINE A | EVP and CFO | 6.68K |
| TUMOLO ANNETTE | Executive Vice President | 4.59K |
| HUTTON RONALD W | Vice President and Treasurer | 4.14K |
| ERNST TIMOTHY S | EVP, General Counsel & Sec | 2.42K |
| WRIGHT DARA | EVP, President, CDG | 1.5K |
| LAST ANDREW J. | EVP, Chief Operating Officer | 1.28K |
| HALL SHANNON | Executive Vice President | 565 |
| HINCKLEY GREGORY K | director | 500 |
| DASKAL ILAN | EVP, Chief Financial Officer | 9 |
| RAMALINGAM AJIT | SVP, Chief Accounting Officer | 0 |
| STARK JAMES R | VP, Corporate Controller | 0 |
